...
机译:血浆LySO-GB3作为生物标志物的疗效,用于从多特异性诊所选择具有遗传分析的多特异性疾病的高危患者(Vol 21,PG 512,2019)
Niigata Univ Dept Clin Nephrosci Grad Sch Med &
Dent Sci Niigata Japan;
Sanofi KK Sanofi Genzyme Med Operat Rare Dis Med Med Sci Liaison Tokyo Japan;
Niigata Univ Dept Clin Nephrosci Grad Sch Med &
Dent Sci Niigata Japan;
Niigata Univ Dept Clin Nephrosci Grad Sch Med &
Dent Sci Niigata Japan;
Niigata Univ Dept Clin Nephrosci Grad Sch Med &
Dent Sci Niigata Japan;
Chiba Childrens Hosp Dept Metab Chiba Japan;
Chiba Childrens Hosp Dept Metab Chiba Japan;
Dokkyo Med Univ Dept Pediat Koshigaya Hosp Koshigaya Japan;
Tohoku Univ Grad Sch Med Dept Cardiovasc Med Sendai Miyagi Japan;
Tohoku Univ Grad Sch Med Dept Cardiovasc Med Sendai Miyagi Japan;
Nishinomiya Watanabe Cardiovasc Ctr Nishinomiya Hyogo Japan;
Nishinomiya Watanabe Cardiovasc Ctr Nishinomiya Hyogo Japan;
Fujinomiya City Gen Hosp Dept Cardiol Fujinomiya Japan;
Okayama Univ Dept Human Resource Dev Dialysis Therapy Kidney D Grad Sch Med Dent &
Pharmaceut Sci;
Okayama Univ Dept Human Resource Dev Dialysis Therapy Kidney D Grad Sch Med Dent &
Pharmaceut Sci;
Sukoyaka Clin Gifu Japan;
Gifu Univ Dept Chron Kidney Dis Grad Sch Med Gifu Japan;
Yamaguchi Prefectural Grand Med Ctr Hofu Japan;
Dokkyo Med Univ Dept Cardiovasc Med Mibu Tochigi Japan;
Iwaki Kyoritsu Gen Hosp Dept Cardiol Internal Med Iwaki Fukushima Japan;
Kashiwazaki Gen Hosp &
Med Ctr Dept Nephrol Kashiwazaki Japan;
Japanese Red Cross Asahikawa Hosp Div Neurol Asahikawa Hokkaido Japan;
Tokyo Teishin Hosp Dept Nephrol Tokyo Japan;
Tokyo Teishin Hosp Dept Nephrol Tokyo Japan;
Japanese Red Cross Hamamatsu Hosp Dept Cardiol Hamamatsu Shizuoka Japan;
Japanese Red Cross Hamamatsu Hosp Dept Cardiol Hamamatsu Shizuoka Japan;
Niigata Univ Biosci Med Res Ctr Div Med Genet Med &
Dent Hosp Niigata Japan;
Tokyo Womens Med Univ Dept Cardiol Tokyo Japan;
Showa Univ Div Cardiol Fujigaoka Hosp Yokohama Kanagawa Japan;
Hamamatsu Univ Sch Med Div Cardiol Internal Med 3 Hamamatsu Shizuoka Japan;
GlycoPharma Corp Oita Japan;
机译:血浆LySO-GB3作为生物标志物的疗效,用于从多特异性诊所选择具有遗传分析的多特异性疾病的高危患者(Vol 21,PG 512,2019)
机译:血浆Lyso-GB3作为生物标志物的疗效,用于从多特异性诊所选择高风险患者的遗传分析(第21卷,PG 44,2019)
机译:血浆Lyso-GB3作为选择高风险患者的遗传分析,血浆Lyso-GB3作为生物标志物选择高危诊所的生物标志物
机译:从多专科诊所中选择血浆lyso-Gb3作为生物标志物从多专科诊所选择高危Fabry疾病患者的生物标记物的有效性
机译:校正:血浆LySO-GB3作为生物标志物的疗效,用于从多特异性诊所选择高危患者的生物标志物进行遗传分析